Optical And Cross-Sectional Imaging Technologies For Bladder Cancer.
Bernhard M. Kiss, Gautier Marcq, Joseph C Liao
Published 2018 · Medicine
Download PDFAnalyze on Scholarcy
Optical and cross-sectional imaging plays critical roles in bladder cancer diagnostics. White light cystoscopy remains the cornerstone for the management of non-muscle-invasive bladder cancer. In the last decade, significant technological improvements have been introduced for optical imaging to address the known shortcomings of white light cystoscopy. Enhanced cystoscopy modalities such as blue light cystoscopy and narrowband imaging survey a large area of the urothelium and provide contrast enhancement to detect additional lesions and decrease cancer recurrence. However, higher false-positive rates accompany the gain of sensitivity. Optical biopsy technologies, including confocal laser endomicroscopy and optical coherence tomography, provide cellular resolutions combined with subsurface imaging, thereby enabling optical-based cancer characterization, and may lead to real-time cancer grading and staging. Coupling of fluorescently labeled binding agents with optical imaging devices may translate into high molecular specificity, thus enabling visualization and characterization of biological processes at the molecular level. For cross-sectional imaging, upper urinary tract evaluation and assessment potential extravesical tumor extension and metastases are currently the primary roles, particularly for management of muscle-invasive bladder cancer. Multi-parametric MRI, including dynamic gadolinium-enhanced and diffusion-weighted sequences, has been investigated for primary bladder tumor detection. Ultrasmall superparamagnetic particles of iron oxide (USPIO) are a new class of contrast agents that increased the accuracy of lymph node imaging. Combination of multi-parametric MRI with positron emission tomography is on the horizon to improve accuracy rates for primary tumor diagnostics as well as lymph node evaluation. As these high-resolution optical and cross-sectional technologies emerge and develop, judicious assessment and validation await for their clinical integration toward improving the overall management of bladder cancer.
This paper references
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder.
Seth P. Lerner (2012)
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Marko Babjuk (2013)
Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases.
Urs E Studer (1990)
Surface-enhanced Raman scattering in cancer detection and imaging.
Marc Vendrell (2013)
Bladder cancer: epidemiology, staging and grading, and diagnosis.
Ziya Kırkalı (2005)
PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer
Firas Aljabery (2015)
Intravesical real-time imaging and staging of bladder cancer: Use of optical coherence tomography
Vengatesh K. Sengottayan (2008)
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
Michael Rink (2013)
Immunohistochemical Expression of Prostate Stem Cell Antigen in Cystoprostatectomies with Incidental Prostate Cancer
Roberta Mazzucchelli (2009)
A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study
Alberto Lapini (2012)
Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
Pengfei Shen (2012)
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Edward A. Neuwelt (2009)
Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers.
Francesco Greco (2014)
Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis.
Changjian Zheng (2012)
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Keith S. Chan (2009)
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Yves Fradet (2007)
Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.
Adam S. Kibel (2009)
Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Dmitry Daniltchenko (2005)
Ying Pan antibody Endoscopic molecular imaging of human bladder cancer using a CD 47
Ying Pan (2014)
Targeting the metabolic microenvironment of tumors.
Kate M. Bailey (2012)
Registration of free-hand OCT daughter endoscopy to 3D organ reconstruction.
Kristen L. Lurie (2016)
Recent advances in imaging cancer of the kidney and urinary tract.
Susan Hilton (2014)
Advances in imaging technologies in the evaluation of high-grade bladder cancer.
Dimitar V Zlatev (2015)
Argon laser induced autofluorescence may distinguish between normal and tumor human urothelial cells: a microspectrofluorimetric study.
Maurice Anidjar (1996)
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
Harry W. Herr (2008)
Histopathological "self control" in transurethral resection of bladder tumours.
Z. Kolozsy (1991)
Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
Mathieu Rouanne (2014)
Computed tomography urography for diagnosing bladder cancer.
B. W. Turney (2006)
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Christopher Blick (2012)
A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications.
Evelyne C. C. Cauberg (2009)
Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Dieter Jocham (2005)
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
Arnulf Stenzl (2010)
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Nacera Amara (2001)
Novel endoscopic diagnosis for bladder cancer.
Seth P. Lerner (2015)
Targeting diseased tissues by pHLIP insertion at low cell surface pH
Oleg A Andreev (2014)
Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis.
Graham Mowatt (2011)
Optical coherence tomography for bladder cancer - ready as a surrogate for optical biopsy? - Results of a prospective mono-centre study
Alexander H. Karl (2010)
The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro.
Paul A. Crow (2004)
Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.
Stephen J. Cina (2001)
5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Marko Babjuk (2005)
Diagnosis of bladder tumours in patients with macroscopic haematuria: A prospective comparison of split-bolus computed tomography urography, magnetic resonance urography and flexible cystoscopy
Karen L Gandrup (2015)
Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography.
Hugang Ren (2009)
Interobserver agreement of confocal laser endomicroscopy for bladder cancer.
Timothy Chang (2013)
Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Alvin C. Goh (2007)
Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer.
Henry Goodfellow (2014)
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
James E. Montie (2005)
2016) Current status of lymph node imaging in bladder and prostate cancer
B Kiss (2016)
Appearance of enhanced tissue features in narrow-band endoscopic imaging.
Kazuhiro Gono (2004)
* Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer : A Systematic Review and Cumulative Analysis of Prospective Studies
Hopital Cantonal (2010)
Intravesical α-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude Mice
Birgit Pfost (2009)
Tumor characteristics of urothelial carcinoma on multidetector computerized tomography urography.
Li-Jen Wang (2010)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.
Sam S. Chang (2016)
Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
Kai-wen Li (2013)
Family of pH (low) insertion peptides for tumor targeting
Dhammika Weerakkody (2013)
Digital Mapping of the Urinary Bladder: Potential for Standardized Cystoscopy Reports.
Maximilian C. Kriegmair (2017)
Current Status of Lymph Node Imaging in Bladder and Prostate Cancer.
Bernhard Kiss (2016)
Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
James Ryan Mark (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham (2012)
Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study.
Christof Schaefauer (2013)
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract.
Michael B. Wallace (2010)
Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
Achim Fleischmann (2005)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk (2017)
[Narrow band imaging-assisted holmium laser resection reduced the recurrence rate of non-muscle invasive bladder cancer: a prospective, randomized controlled study].
Tianjia Ma (2015)
Probe-based confocal laser endomicroscopy of the urinary tract: the technique.
Timothy Chang (2013)
Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients.
Raymond Oyen (1994)
Is a limited lymph node dissection an adequate staging procedure for prostate cancer?
Pia Bader (2002)
The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Proto
Seiji Prof Naito (2016)
Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography.
Michael J. Manyak (2005)
Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study.
Siamak Daneshmand (2012)
Grading and staging of bladder carcinoma in transurethral resection specimens: correlation with 105 matched cystectomy specimens.
Michael J. Droller (2000)
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
Frederic D. Birkhaeuser (2013)
The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology.
Christopher S. D. Lee (2008)
Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer.
Evelyne C. C. Cauberg (2010)
Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors
Joergen Carlsson (2011)
Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.
Harriet C. Thoeny (2014)
Spectroscopic view of life and work of the Nobel Laureate Sir C.V. Raman.
Amrith Raj Rao (2007)
Intraoperative optical imaging and tissue interrogation during urologic surgery
Mark Shu-Chien Hsu (2014)
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.
Herbert Barton Grossman (2012)
Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness
Shuichiro Kobayashi (2011)
Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI
Andrew B. Rosenkrantz (2017)
New optical imaging technologies for bladder cancer: considerations and perspectives.
Jen‐Jane Liu (2012)
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
Maximilian Burger (2013)
Surface Mosaics of the Bladder Reconstructed From Endoscopic Video for Automated Surveillance
Timothy D. Soper (2012)
Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy
Katherine Wu (2011)
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.
Maurizio A. Brausi (2002)
Optical Biopsy of Bladder Cancer Using Crowd-Sourced Assessment.
Stephanie P Chen (2016)
Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo
Jovana Golijanin (2016)
In vivo bladder cancer diagnosis by high-volume Raman spectroscopy.
Ronald O.P. Draga (2010)
Bladder cancer detection with CT urography in an Academic Medical Center.
Cheryl A. Sadow (2008)
A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: A prospective, randomized and multi-center study
Zhangqun Ye (2015)
Identification of bladder wall layers by Raman spectroscopy.
Bas W D de Jong (2002)
Narrow Band Imaging: Technology Basis and Research and Development History
Kazuhiro Gono (2015)
Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Jörg Schmidbauer (2004)
Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
Bárbara Hermes (2008)
Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment?
Stefan Tritschler (2011)
Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
Martin C. Schumacher (2010)
Memoir on inventing the confocal scanning microscope
Marvin Minsky (1988)
Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder.
R. Klän (1991)
Chapter 4 Principles of confocal microscopy
J. Paul Robinson (2001)
FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Greet Swinnen (2010)
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
Eric J. Lepin (2010)
Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging.
Colm J. Mcmahon (2010)
3D reconstruction of cystoscopy videos for comprehensive bladder records.
Kristen L. Lurie (2017)
A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer
Yiquan Xiong (2017)
Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
Jörg Schmidbauer (2009)